Orient Pharma Co., Ltd.

Orient Pharma Co., Ltd. is a pharmaceutical company specializing in the research, development, manufacturing, and licensing of both generic and value-added drugs. Established in 2008 and headquartered in Taiwan, the company operates a GMP-certified facility recognized by regulatory authorities in Taiwan, the United States, the United Kingdom, and Australia. Its primary focus spans key therapeutic areas such as neuroscience, autoimmune disorders, and cardiovascular diseases, supporting conditions like Alzheimer’s disease, Parkinson’s disease, sialorrhea, tuberculosis, and attention deficit hyperactivity disorder. Orient Pharma pioneers advanced drug delivery technologies, including multi-stage controlled release systems, transdermal patches, oral disintegrating tablets, and micro granules. Notable product brands include Methydur, Tonvasca, Zulitor, Trokendi, and Vancover. The company is recognized for its agile approach and effective global partnerships, collaborating extensively with R&D organizations in the United States, Europe, and Japan to drive innovation and intellectual property protection. Orient Pharma plays a significant role in both the Taiwanese and international healthcare industries by providing high-quality pharmaceutical solutions for major health challenges.